Trials / Recruiting
RecruitingNCT06823037
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
HAPPI (Hormonal Contraception Access Through Pharmacist Prescribing Implementation): Phase 2 (Aim 1)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- EMPOWERX INC · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to learn if use of the HAPPI software can improve pharmacist-provided birth control services. The main questions it aims to answer are: 1. Does the HAPPI software make it easier for pharmacists to provide birth control services in their pharmacy? 2. Does the HAPPI software make it easier for patients to access birth control? Researchers will compare pharmacists' implementation and patients' access when using the HAPPI software and when not using the HAPPI software to see if the software improves implementation and access. Participants will include pharmacists and patients. Pharmacists will be asked to provide birth control services as normal while using the HAPPI software. Patients will be asked to receive birth control services from a pharmacist as normal, while using the HAPPI software.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | HAPPI software | We will enroll 15 community pharmacies. These 15 pharmacies will continue to provide birth control services as normal for several months (control). Then, we will introduce the intervention: the HAPPI software. The pharmacies will continue to provide birth control services while using the HAPPI software in place of any paper or electronic processes that they were previously using. The results will then be compared between the control and the intervention period. |
Timeline
- Start date
- 2025-10-09
- Primary completion
- 2026-08-31
- Completion
- 2026-08-31
- First posted
- 2025-02-12
- Last updated
- 2025-12-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06823037. Inclusion in this directory is not an endorsement.